ND-L02-s0201 regulatory update

FDA granted Fast Track designation to ND-L02-s0201 from Nitto to treat non-alcoholic steatohepatitis (NASH) and HCV liver fibrosis. The injectable formulation of a vitamin A-coupled lipid nanoparticle...